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   Allergic	  asthma	  affects	  over	  300	  million	  people	  worldwide.	  Multiple	  factors	  have	  
been	  shown	  to	  alter	  an	  individuals'	  susceptibility	  to	  this	  allergic	  airway	  disease	  such	  as	  
exposure	  to	  polycyclic	  aromatic	  hydrocarbons	  (PAHs),	  endotoxin,	  and	  environmental	  
tobacco	  smoke	  (ETS).	  Prenatal	  exposure	  to	  these	  contaminants,	  especially	  ETS,	  has	  been	  
shown	  to	  increase	  risk	  for	  an	  individuals’	  asthma	  risk,	  however,	  the	  mechanism	  by	  which	  
this	  happens	  is	  still	  unknown.	  Epigenetic	  alterations,	  particularly	  DNA	  methylation	  
patterns,	  have	  been	  introduced	  as	  a	  proposed	  mechanism. The	  goals	  of	  this	  project	  were	  to	  
use	  a	  house	  dust	  mite	  (HDM)	  murine	  model	  of	  asthma	  to	  determine	  the	  methylation	  
alterations	  of	  asthma-­‐associated	  genes	  and	  the	  immunological	  effects	  after	  prenatal	  
exposure	  to	  a	  low	  dose	  of	  ETS.	  The	  asthma-­‐associated	  genes	  used	  in	  this	  experiment	  are	  
genes	  encoding	  for:	  Th2	  cytokines,	  Il-­‐4	  and	  Il-­‐13,	  Th1	  cytokine,	  Ifn-­‐γ,	  and	  regulatory	  
molecule,	  Foxp3.	  Male	  C57BL/6	  mice	  were	  exposed	  prenatally	  to	  1.0	  mg/m3	  of	  ETS	  and	  
later	  challenged	  with	  HDM	  at	  6	  weeks	  old.	  	  Promoter	  regions	  of	  the	  asthma-­‐associated	  
genes	  were	  analyzed	  via	  bisulfite	  sequencing,	  using	  a	  Qiagen®	  PyroMark	  Q96MD	  
pyrosequencer.	  Cytokines	  in	  bronchoalveolar	  lavage	  fluid	  (BALF)	  were	  analyzed	  using	  
Quantikine	  ELISA	  (R&D)	  for	  IL-­‐13	  and	  Mesoscale	  Discovery®	  Pro-­‐inflammatory	  Panel	  1	  kit	  
for	  IFN-­‐γ,	  IL-­‐4	  and	  IL-­‐5.	  Serum	  IgE	  levels	  were	  determined	  using	  a	  BioLegend	  IgE	  ELISA	  kit.	  
We	  concluded	  that	  prenatal	  exposure	  to	  low	  doses	  of	  ETS	  causes	  a	  severe	  increase	  in	  the	  
immune	  response	  when	  challenged	  with	  HDM.	  We	  also	  found	  Ifn-­‐γ	  to	  be	  hypermethylated	  
in	  the	  HDM	  group	  and	  further	  hypermethylated	  after	  prenatal	  ETS	  exposure	  and	  Il-­‐4	  to	  be	  
hypomethylated	  in	  the	  HDM	  group	  and	  further	  hypomethylated	  after	  ETS	  exposure.	  This	  
suggests	  that	  prenatal	  ETS	  exposure	  increases	  the	  susceptibility	  to	  an	  allergic	  and	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The	  prevalence	  of	  asthma,	  the	  most	  common	  chronic	  disease	  in	  children,	  has	  
increased	  dramatically	  during	  the	  last	  two	  to	  three	  decades	  (Bloemen	  et	  al.	  2007).	  
According	  the	  the	  American	  Academy	  of	  Allergy,	  Asthma	  &	  Immunology,	  more	  than	  300	  
million	  individuals	  are	  affected	  globally,	  and	  that	  statistic	  is	  predicted	  to	  increase	  by	  over	  
100	  million	  before	  the	  year	  2025	  (AAAAI).	  	  People	  diagnosed	  with	  allergic	  asthma	  
experience	  intense,	  recurring	  episodes	  of	  wheezing,	  shortness	  of	  breath,	  chest	  tightness	  
and	  cough.	  In	  2008,	  approximately	  250,000	  people	  died	  from	  preventable	  asthma-­‐related	  
complications	  (AAAAI).	  Asthma	  is	  not	  only	  a	  detrimental	  public	  health	  burden,	  but	  also	  an	  
economic	  burden	  as	  it	  accounted	  for	  more	  than	  $10	  billion	  in	  direct	  health	  care	  costs	  in	  the	  
United	  States	  annually	  (Eder	  et	  al.	  2006).	  	  Even	  with	  increased	  research,	  asthma	  continues	  
to	  have	  a	  complex	  and	  poorly	  understood	  etiology,	  involving	  both	  genetic	  and	  
environmental	  factors.	  	  
It	  is	  thought	  that	  early	  life	  exposures	  severely	  increase	  one’s	  risk	  for	  asthma	  
development	  later	  in	  life.	  The	  early	  origins	  of	  adult	  disease	  hypothesis	  proposes	  that	  
adverse	  influences	  or	  exposures	  early	  in	  development	  cause	  organs	  to	  undergo	  in-­‐utero	  
developmental	  programming	  which	  predetermines	  subsequent	  physiologic	  and	  metabolic	  
adaptations	  during	  adult	  life	  which	  increases	  disease	  risk.	  This	  early	  origins	  hypothesis,	  or	  
Barker	  Hypothesis	  (De	  Boo	  &	  Harding	  2006),	  has	  been	  introduced	  as	  a	  possible	  underlying	  
cause	  for	  development	  of	  allergic	  asthma.	  Early	  life	  or	  in-­‐utero	  exposures	  to	  harmful	  
environmental	  toxins	  may	  alter	  the	  epigenetic	  programming	  of	  genes	  related	  to	  allergic	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asthma.	  Epigenetic	  alterations	  are	  heritable	  changes	  that	  can	  regulate	  gene	  activity	  without	  
altering	  the	  primary	  DNA	  sequences.	  With	  respect	  to	  allergic	  or	  asthma	  phenotypes	  elicited	  
by	  environmental	  exposures,	  Th2	  cytokines	  (IL-­‐4,	  IL-­‐5,	  IL-­‐13),	  transcriptional	  factors	  (e.g.	  
GATA-­‐3),	  and	  T-­‐regulatory	  (Treg)	  factor	  (FOXP3)	  associated	  with	  allergic	  disease	  (Ho	  
2010;	  I.	  J.	  Wang	  et	  al.	  2013;	  Bégin	  &	  Nadeau	  2014)	  have	  also	  been	  shown	  to	  be	  modulated	  
by	  epigenetic	  alterations.	  	  
	   Of	  early	  life	  exposures,	  environmental	  tobacco	  smoke	  (ETS)	  continues	  to	  be	  one	  of	  
the	  most	  harmful	  environmental	  toxicants.	  ETS	  exposure	  can	  lead	  to	  poor	  respiratory	  
health	  among	  susceptible	  children,	  and	  still	  remains	  a	  major	  public	  health	  concern.	  
Especially	  prenatal	  exposure	  to	  ETS	  that	  have	  effects	  that	  may	  be	  transmissible	  from	  
mother	  to	  fetus	  has	  been	  associated	  with	  later	  development	  of	  asthma-­‐related	  outcomes	  in	  
children	  and	  adults.	  This	  provides	  compelling	  evidence	  that	  in	  utero	  exposure	  to	  ETS	  
influences	  fetal	  immune	  development	  and	  in	  programming	  for	  the	  susceptibility	  to	  allergic	  
diseases	  (Singh	  et	  al.	  2011).	  This	  early	  exposure	  results	  in	  epigenetic	  modification	  in	  the	  
DNA,	  which	  may	  be	  a	  mechanism	  of	  early	  origins	  of	  adult	  disease.	  
Multiple	  types	  of	  environmental	  and	  occupational	  exposures	  have	  been	  shown	  to	  
modify	  risk	  for	  asthma	  development;	  however,	  these	  factors	  have	  been	  unable	  to	  
independently	  explain	  the	  cause	  of	  asthma.	  Discovery	  of	  preventable	  factors	  and	  the	  
underlying	  mechanisms	  that	  exacerbate	  asthma	  is	  important	  for	  mitigating	  the	  health	  
burden	  of	  this	  childhood	  disease.	  	  
	  
1.1	  Environmental	  Tobacco	  Smoke	  (ETS)	  
Despite	  significant	  declines	  during	  the	  past	  30	  years,	  cigarette	  smoking	  among	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adults	  in	  the	  United	  States	  remains	  widespread,	  and	  significant	  year-­‐to-­‐year	  decreases	  
have	  been	  observed	  only	  sporadically	  in	  recent	  years.	  	  Smoking	  has	  been	  banned	  in	  many	  
public	  places,	  which	  has	  resulted	  in	  a	  general	  decreased	  population	  exposure	  to	  cigarette	  
smoke.	  It	  is	  estimated,	  based	  on	  data	  from	  the	  2012	  National	  Health	  Interview	  Survey	  
(NHIS),	  that	  the	  proportion	  of	  U.S.	  adults	  who	  smoke	  cigarettes	  is	  18.1%	  or	  42.1	  million	  
American	  adults	  (age	  18+).	  This	  is	  not	  dramatically	  less	  than	  in	  2005	  when	  NHIS	  predicted	  
20.9%	  of	  U.S.	  adults	  identified	  as	  smokers	  (Agaku	  et	  al.	  2014). Among	  smoking	  adults,	  
78.4%	  (33.0	  million)	  smoked	  every	  day	  averaging	  14.6	  cigarettes	  per	  day(Centers	  for	  
Disease	  Control	  and	  Prevention	  (CDC)	  2011).	  	  
Second	  hand	  smoke	  (SHS)	  is	  defined	  as	  a	  mixture	  of	  the	  sidestream	  smoke,	  which	  is	  
the	  smoke	  emitted	  from	  the	  burning	  cigarette,	  pipe,	  or	  cigar	  and	  the	  mainstream	  smoke	  
which	  exhaled	  from	  the	  lungs	  of	  the	  smoker.	  SHS	  contains	  more	  than	  4,000	  chemicals,	  
hundreds	  of	  which	  are	  known	  or	  suspected	  carcinogens	  or	  other	  contributors	  to	  adverse	  
health	  effects.	  These	  chemicals	  include,	  but	  are	  certainly	  not	  limited	  to,	  ammonia,	  acrolein,	  
carbon	  monoxide,	  formaldehyde,	  hydrogen	  cyanide,	  nicotine,	  nitrogen	  oxides,	  polycyclic	  
aromatic	  hydrocarbons	  (PAHs),	  and	  sulfur	  dioxide	  (Matt	  et	  al.	  2011).	  These	  chemicals	  are	  
eye	  and	  respiratory	  irritants,	  mutagens,	  carcinogens,	  and	  cardiovascular	  and	  reproductive	  
toxicants(Office	  on	  Smoking	  and	  Health	  (US)	  2006).	  Third	  hand	  smoke	  (THS),	  sometimes	  
referred	  to	  as	  the	  legacy	  of	  tobacco	  smoke,	  consists	  of	  residual	  tobacco	  smoke	  chemicals	  
that	  remain	  on	  surfaces	  and	  in	  dust	  after	  tobacco	  has	  been	  smoked.	  These	  chemicals	  are	  re-­‐
emitted	  into	  the	  gas	  phase,	  or	  react	  with	  other	  compounds	  in	  the	  environment	  to	  yield	  
secondary	  pollutants.	  The	  constituents	  of	  THS	  identified	  to	  date	  include	  nicotine,	  phenol,	  
cresols,	  naphthalene,	  formaldehyde,	  and	  tobacco-­‐	  specific	  nitrosamines,	  and	  many	  others	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(Matt	  et	  al.	  2011).	  	  These	  chemicals	  and	  their	  secondary	  pollutants	  from	  tobacco	  smoke	  can	  
persist	  in	  environments	  long	  after	  the	  tobacco	  smoking	  has	  ceased.	  Some	  of	  the	  pollutants	  
present	  in	  SHS	  predominantly	  remain	  in	  the	  gas	  phase	  and	  can	  be	  removed	  by	  ventilation,	  
but	  a	  significant	  fraction	  of	  SHS	  and	  THS	  adheres	  to	  indoor	  surfaces	  which	  allows	  the	  toxic	  
chemicals	  to	  persist	  for	  a	  longer	  time	  (Matt	  et	  al.	  2011).	  
Exposure	  to	  environmental	  tobacco	  smoke	  (ETS),	  defined	  as	  a	  combination	  of	  SHS	  
and	  THS,	  remains	  a	  major	  public	  health	  concern,	  as	  the	  decrease	  in	  adult	  smokers	  has	  been	  
slight	  and	  intermittent.	  Pregnant	  women	  and	  children	  remain	  most	  susceptible	  to	  the	  
highest	  levels	  of	  ETS	  exposure	  because,	  despite	  the	  increased	  regulations,	  smoking	  in	  one’s	  
home	  or	  automobile	  remains	  legal	  (Office	  on	  Smoking	  and	  Health	  (US)	  2006).	  	  Parental	  
smoking,	  particularly	  maternal	  smoking,	  is	  strongly	  linked	  to	  allergic	  asthma,	  infection	  in	  
children,	  and	  other	  disease	  susceptibility.	  Similarly,	  mice	  exposed	  to	  SHS	  during	  early	  
postnatal	  life	  are	  more	  susceptible	  to	  developing	  respiratory	  infections	  (Claude	  et	  al.	  2012).	  
There	  is	  an	  increase	  in	  convincing	  evidence	  that	  in	  utero	  exposure	  to	  ETS	  influences	  fetal	  
immune	  development	  and	  programming	  influencing	  susceptibility	  to	  allergic	  diseases.	  	  
	  
1.2	  Allergic	  Asthma	  
Allergic	  asthma,	  the	  most	  common	  form	  of	  asthma,	  is	  a	  chronic	  inflammatory	  airway	  
disease	  characterized	  by	  pulmonary	  eosinophilia,	  increased	  mucus	  production	  by	  goblet	  
cells,	  elevated	  immunoglobulin	  E	  (IgE)	  levels	  and	  structural	  remodeling	  of	  the	  airway	  wall,	  
leading	  to	  airway	  obstruction,	  bronchial	  inflammation	  and	  airway	  hyperreactivity	  (AHR)	  to	  
nonspecific	  stimuli.	  The	  allergic	  process	  is	  believed	  to	  result	  from	  allergens	  inducing	  the	  
	  12	  
infiltration	  of	  CD4+	  Th2	  cells,	  eosinophils,	  mast	  cells,	  basophils,	  and	  other	  allergic	  
mediators	  into	  the	  small	  airways.	  Allergen-­‐specific	  CD4+	  Th2	  cells,	  producing	  cytokines	  
such	  as	  IL-­‐4,	  IL-­‐5,	  IL-­‐9	  and	  IL-­‐13	  are	  prevalent	  in	  driving	  the	  mucosal	  inflammation	  in	  
asthma.	  	  
Figure	  1	  illustrates	  a	  schematic	  representation	  of	  the	  inflammatory	  cascade	  in	  
allergic	  asthma	  (Ho	  2010).	  Allergen	  sensitization	  is	  a	  prerequisite	  to	  development	  and	  
initiation	  of	  the	  inflammatory	  cascade.	  Airway	  epithelium	  is	  exposed	  to	  various	  
environmental	  toxicants,	  which	  are	  then	  sampled	  by	  local	  dendritic	  cells	  (DCs).	  The	  
allergen-­‐activated	  DCs	  prime	  naive	  CD4+	  T	  cells	  to	  differentiate	  into	  proinflammatory	  Th2	  
cells	  rather	  than	  infection-­‐fighting	  Th1	  cells,	  whose	  main	  effector	  cells	  are	  macrophages.	  
The	  gradual	  increase	  in	  the	  recruitment	  of	  CD4+	  T	  cells	  toward	  a	  Th2	  phenotype	  is	  
primarily	  driven	  by	  the	  Th2	  cytokines:	  IL-­‐4,	  IL-­‐5,	  IL-­‐9,	  and	  IL-­‐13,	  which	  result	  because	  of	  
heightened	  expression	  of	  transcription	  factor	  GATA-­‐3.	  Briefly,	  IL-­‐4	  generally	  promotes	  IgE	  
production	  and	  is	  involved	  in	  growth	  and	  activation	  of	  mast	  cells,	  IL-­‐5	  promotes	  eosinophil	  
development,	  activation,	  and	  tissue	  recruitment,	  and	  IL-­‐13	  stimulates	  mucus	  production	  
and	  secretion	  (Bloemen	  et	  al.	  2007;	  Verstraelen	  et	  al.	  2008).	  As	  for	  the	  counterpart	  of	  T	  cell	  
differentiation,	  the	  Th2	  cells	  shut	  off	  or	  inhibit	  the	  expression	  of	  IFN-­‐γ	  and	  other	  Th1	  
cytokines,	  such	  as	  IL-­‐2.	  TGF-­‐βalso	  plays	  a	  role	  in	  causing	  naive	  CD4+	  T	  cells	  to	  differentiate	  
into	  FOXP3+	  Treg	  cells	  that	  play	  a	  role	  in	  immune	  tolerance	  and	  regulate	  immune	  processes	  
in	  order	  to	  reduce	  allergic	  or	  inflammatory	  responses.	  Alveolar	  macrophages	  play	  a	  dual	  
role	  in	  toxicant/allergen	  elimination	  as	  well	  as	  suppression	  of	  the	  responses	  for	  airway	  
repair	  and	  remodeling.	  Once	  activated,	  Th2	  cells	  have	  the	  capacity	  to	  recruit	  secondary	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effector	  cells	  such	  as	  macrophages,	  basophils	  and	  eosinophils	  to	  the	  site	  of	  inflammation	  


















The	  early	  origins	  of	  adult	  disease	  hypothesis	  proposes	  that	  adverse	  influences	  or	  
exposures	  early	  in	  development	  cause	  organs	  to	  undergo	  in-­‐utero	  developmental	  
programming	  which	  predetermines	  subsequent	  physiologic	  and	  metabolic	  adaptations	  
during	  adult	  life	  which	  increases	  disease	  risk.	  	  This	  hypothesis	  originated	  from	  a	  study	  on	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English	  populations	  dating	  back	  to	  the	  early	  20th	  century,	  led	  by	  Dr.	  DJ	  Barker,	  that	  
determined	  a	  relationship	  between	  low	  birth	  weight	  and	  the	  development	  of	  coronary	  
heart	  disease	  (Barker	  2004).	  This	  study	  inspired	  other	  studies	  to	  correlate	  birth	  weight	  to	  
disease	  risk	  in	  adulthood,	  including	  type	  II	  diabetes,	  hyperlipidemia,	  and	  even	  allergic	  
asthma	  (De	  Boo	  &	  Harding	  2006).	  The	  theory	  behind	  this	  relationship	  is	  that	  early	  life	  
exposures	  to	  environmental	  and	  lifestyle	  factors	  affect	  the	  programming	  of	  the	  offspring.	  
Programming	  is	  the	  process	  whereby	  a	  stimulus	  or	  insult	  during	  a	  sensitive	  period	  of	  time,	  
or	  window,	  has	  long-­‐term	  irreversible	  developmental	  effects	  (De	  Boo	  &	  Harding	  2006).	  	  
One	  of	  the	  proposed	  mechanisms	  of	  programming	  is	  epigenetics.	  	  
Epigenetic	  modifications	  are	  heritable	  changes	  that	  can	  regulate	  gene	  activity	  or	  
expression	  without	  altering	  the	  primary	  DNA	  sequences.	  	  Environmental	  exposures	  and	  
maternal	  diet	  early	  in	  development	  have	  shown	  to	  alter	  epigenetic	  patterns	  of	  offspring,	  
especially	  DNA	  methylation	  (Jirtle	  &	  Skinner	  2007).	  
	  
1.3.1	  Epigenetic	  Mechanisms	  
	   	   There	  are	  three	  epigenetic	  mechanisms	  studied	  today:	  histone	  modification,	  non-­‐
coding	  (micro)	  RNA,	  and	  DNA	  methylation.	  Histones	  are	  a	  family	  of	  alkaline	  proteins	  that	  
associate	  with	  DNA	  in	  the	  nucleus	  to	  aid	  in	  the	  condensation	  of	  nucleosomes,	  the	  structural	  
unit	  of	  chromatin.	  Histones	  can	  be	  modified	  by	  methylation,	  acetylation,	  phosphorylation,	  
addition	  of	  various	  amino	  acids,	  ubiquitylation	  as	  well	  as	  others	  (Yang	  &	  Schwartz	  2012).	  
These	  modifications	  affect	  the	  condensation	  of	  DNA	  and	  may	  block	  or	  open	  transcription	  
sites.	  Another	  epigenetic	  mechanism	  is	  microRNA,	  which	  are	  small	  non-­‐coding	  RNA	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segments	  that	  block	  translation	  of	  messenger	  RNA	  into	  proteins	  (Rodriguez	  et	  al.	  2004).	  
MicroRNAs	  can	  inhibit	  translation	  in	  two	  ways;	  the	  first	  is	  by	  binding	  to	  single	  stranded	  
mRNA	  and	  not	  allowing	  ribosome	  to	  bind.	  Alternatively,	  they	  can	  bind	  to	  the	  ribosome	  
itself	  so	  that	  the	  ribosome	  cannot	  bind	  to	  other	  mRNAs	  to	  make	  proteins.	  Non-­‐coding	  RNA	  
is	  the	  least	  studied	  epigenetic	  mechanism,	  but	  holds	  great	  promise	  for	  disease	  pathology	  
and	  drug	  development	  (Yang	  &	  Schwartz	  2012).	  Lastly,	  the	  most	  studied	  epigenetic	  
mechanism	  is	  DNA	  methylation,	  where	  a	  methyl	  group	  is	  added	  to	  the	  5-­‐position	  of	  the	  
nucleotide	  cytosine,	  particularly	  at	  cytosine-­‐guanine	  dinucleotide	  residues	  (CpG).	  	  There	  
are	  approximately	  30	  million	  CpG	  sites	  within	  the	  human	  genome	  and	  they	  tend	  to	  cluster	  
within	  gene	  promoter	  regions	  (100-­‐1000	  bp	  upstream	  of	  the	  start	  codon),	  these	  clusters	  
are	  referred	  to	  as	  CpG	  islands.	  Hypermethylation	  of	  these	  islands	  in	  gene	  promoter	  regions	  
leads	  to	  decreased	  gene	  expression	  and	  hypomethylation	  elicits	  an	  increase	  in	  active	  gene	  
transcription	  (Yang	  &	  Schwartz	  2012).	  	  Figure	  2	  illustrates	  how	  DNA	  methylation,	  histone	  
modification	  and	  non-­‐coding	  RNA	  inhibit	  the	  transcription	  of	  mRNA	  and	  gene	  expression.	  
White	  circles	  symbolize	  unmethylated	  CpGs	  and	  black	  circles	  denote	  methylated	  CpGs.	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Figure	  2.	  Epigenetic	  mechanisms	  and	  gene	  expression	  (Yang	  &	  Schwartz	  2012)	  
	  
1.3.2	  Epigenetics	  and	  Asthma	  
With	  respect	  to	  allergic	  or	  asthma	  phenotypes	  elicited	  by	  environmental	  exposures,	  
epigenetics,	  especially	  DNA	  methylation,	  is	  thought	  to	  play	  a	  huge	  role	  in	  antigen	  
presenting	  cell	  (APC),	  T-­‐cell	  differentiation	  and	  allergic	  cytokine	  production	  (Yang	  &	  
Schwartz	  2012).	  Differentiation	  of	  APCs	  is	  a	  critical	  first	  step	  to	  the	  differentiation	  of	  naïve	  
T-­‐cells	  into	  effector	  T-­‐cells	  (Th1,	  Th2,	  or	  Th17)	  or	  regulatory	  T-­‐cells	  (Treg)	  (Miller	  &	  Ho	  
2008).	  	  In	  allergic	  asthma,	  there	  is	  a	  trend	  to	  suppress	  the	  Th1	  profile	  and	  favor	  a	  Th2	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response	  with	  epigenetic	  alterations	  as	  a	  proposed	  mechanism	  (Calderon	  et	  al.	  2009).	  Th2	  
cytokines	  IL-­‐4,	  IL-­‐5,	  IL-­‐13	  and	  transcription	  factor	  GATA-­‐3	  have	  been	  shown	  to	  have	  
promoter	  regions	  which	  are	  generally	  demethylated	  under	  allergic	  conditions	  (Miller	  &	  Ho	  
2008).	  In	  parallel,	  expression	  of	  IFN-­‐γ	  in	  Th2	  cells	  is	  silenced	  by	  increased	  promoter	  
methylation	  (Jones	  &	  Chen	  2006).	  	  Studies	  also	  suggest	  that	  expression	  of	  Treg	  factor,	  
Foxp3,	  is	  also	  epigenetically	  regulated	  by	  DNA	  methylation.	  FOXP3	  expressing	  T-­‐cells	  play	  
a	  crucial	  role	  in	  maintaining	  immune	  homeostasis	  and	  preventing	  autoimmune	  reactivity	  
and	  hypersensitivity	  (Huehn	  et	  al.	  2009).	  Excess	  DNA	  methylation	  on	  histones	  and	  within	  
CpG	  islands	  of	  the	  promoter	  region	  block	  transcription	  factors	  and	  prevent	  stable	  FOXP3	  
expression	  in	  effector	  T	  cells,	  while	  cells	  stably	  expressing	  FOXP3	  are	  demethylated	  in	  
these	  regions	  (Lal	  et	  al.	  2009).	  In	  addition,	  a	  study	  population	  of	  monozygotic	  twins	  
discordant	  for	  asthma	  concluded	  that	  FOXP3	  and	  IFN-­‐Y	  were	  shown	  to	  be	  hypermethylated	  
in	  white	  blood	  cells	  from	  the	  twins	  with	  asthma.	  This	  hypermethylation	  was	  also	  increased	  
if	  the	  twins	  were	  also	  discordant	  for	  second	  hand	  smoke	  exposure	  (Runyon	  et	  al.	  2012).	  
DNA	  methylation	  patterns	  are	  critical	  for	  normal	  T	  cell	  differentiation,	  but	  early	  life	  
exposures	  to	  various	  agents,	  including	  tobacco	  smoke,	  polycyclic	  aromatic	  hydrocarbons	  
(PAHs),	  particulate	  matter,	  and	  maternal	  diet	  can	  alter	  these	  patterns	  and	  contribute	  to	  
asthma	  pathogenesis	  (Ho	  2010).	  Few	  studies	  have	  been	  reported	  analyzing	  the	  effect	  of	  
prenatal	  tobacco	  smoke	  exposure	  and	  how	  it	  may	  potentially	  contribute	  to	  asthma	  etiology	  
by	  epigenetic	  mechanisms,	  particularly	  DNA	  methylation.	  	  
	  
1.4	  Specific	  Aims	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This	  study	  was	  designed	  to	  research	  the	  effect	  of	  prenatal	  ETS	  exposure	  on	  
epigenetic	  programming	  and	  hypothesized	  increased	  susceptibility	  to	  development	  of	  
allergen-­‐induced	  airway	  inflammation.	  In	  order	  to	  complete	  this	  goal,	  I	  used	  a	  HDM	  
allergen-­‐induced	  mouse	  model	  of	  asthma	  to	  examine	  the	  effect	  of	  in	  utero	  ETS	  exposure	  on	  
susceptibility	  to	  an	  asthmatic	  phenotype	  via	  the	  proposed	  mechanism	  of	  epigenetic	  
programming	  by	  alterations	  in	  DNA	  methylation	  of	  genes	  associated	  with	  asthma.	  For	  
purposes	  of	  consistency	  and	  to	  minimize	  confounding	  factors,	  I	  considered	  only	  male	  mice	  
for	  this	  experiment.	  My	  central	  hypothesis	  states	  that	  prenatal	  exposure	  to	  ETS	  in	  utero	  will	  
lead	  to	  alterations	  in	  DNA	  methylation	  that	  will	  correlate	  with	  increased	  severity	  and/or	  risk	  
for	  indictors	  of	  asthma	  development.	  I	  created	  the	  following	  aims	  to	  test	  this	  hypothesis:	  
	  
Specific	  Aim	  1:	  Epigenetic	  Alterations	  
Determine	  the	  promoter	  region	  DNA	  methylation	  of	  genes	  associated	  with	  allergic	  
phenotype	  of	  male	  C57BL/6	  mice	  exposed	  to	  1.0	  mm/m3	  environmental	  tobacco	  smoke	  
(ETS)	  prenatally	  and	  inoculated	  and	  challenged	  with	  HDM	  at	  8	  weeks	  old	  and	  relate	  to	  gene	  
expression.	  My	  hypothesis	  states	  that	  promoters	  of	  regulatory	  molecules	  (Ifn-­‐γ,	  Foxp3)	  will	  
be	  hypermethylated	  and	  promoter	  regions	  of	  pro-­‐allergic	  cytokine	  (Il-­‐4,	  Il-­‐13)	  will	  be	  
hypomethylated.	  	  The	  effects	  on	  the	  following	  epigenetic	  alterations	  were	  evaluated:	  
(i) Promoter	  methylation	  of	  Th2	  genes:	  Il-­‐4	  and	  Il-­‐13	  
(ii) Promoter methylation of Th1	  gene:	  Ifn-­‐γ 
(iii) Promoter	  methylation	  of	  Treg	  gene:	  Foxp3 
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Specific	  Aim	  2:	  Immunologic	  Alterations	  
Determine	  extent	  of	  immunological	  susceptibility	  to	  HDM	  challenge	  after	  prenatal	  
exposure	  to	  ETS.	  I	  hypothesized	  that	  mice	  exposed	  prenatally	  to	  ETS	  will	  have	  a	  more	  
severe	  immune	  response	  (increased	  serum	  IgE,	  mucus	  production,	  presence	  of	  eosinophils,	  
and	  IL-­‐4,	  IL-­‐5	  and	  IL-­‐13	  production	  in	  BAL	  fluid)	  to	  HDM	  challenge,	  therefore	  increasing	  
their	  susceptibility	  and	  severity	  of	  disease.	  	  The	  effect	  on	  the	  following	  responses	  were	  
evaluated:	  
(i) Cytokines	  present	  in	  BAL	  fluid	  (IL-­‐4,	  IL-­‐5,	  IL-­‐13,	  and	  IFN-­‐	  γ)	  
(ii) Immune	  cell	  types	  present	  in	  BAL	  fluid	  














C57BL6	  mice	  were	  purchased	  from	  Harlan	  Laboratories,	  Indianapolis	  Indiana.	  All	  
mice	  were	  maintained	  in	  pathogen-­‐free	  conditions	  in	  the	  animal	  facility	  at	  either	  University	  
of	  California	  –	  Davis	  (Davis,	  CA)	  or	  the	  University	  of	  Montana	  (Missoula,	  MT).	  	  All	  
experiments	  were	  performed	  to	  the	  guidelines	  of	  the	  National	  Institutes	  of	  Health	  and	  
approved	  by	  the	  University	  of	  Montana	  Institutional	  Animal	  Care	  and	  Use	  Committee	  
(IACUC).	  
	  
2.2	  ETS	  Exposure	  
Collaborators	  at	  UC	  Davis’	  CHE	  animal	  facilities	  carried	  out	  the	  ETS	  exposure.	  The	  
mice	  used	  in	  my	  experiment	  were	  a	  small	  part	  of	  the	  larger	  exposure	  project.	  The	  larger	  
project	  consisted	  of	  mating	  of	  2	  female	  mice,	  paired	  with	  1	  male	  mouse/cage	  to	  create	  a	  
timed-­‐pregnant	  exposure	  scenario.	  Specifically,	  36	  female	  and	  18	  male	  C57BL6	  mice	  were	  
used	  for	  breeding.	  Following	  confirmation	  of	  a	  vaginal	  plug,	  18	  female	  mice	  were	  exposed	  
to	  either	  filtered	  air	  (FA)	  or	  ETS	  through	  gestation.	  For	  the	  control	  group,	  timed-­‐pregnant	  
mice	  were	  exposed	  only	  to	  filtered	  air	  only	  for	  24	  h	  7d/week	  for	  the	  duration	  of	  the	  study.	  
For	  the	  ETS	  exposed	  group,	  timed-­‐pregnant	  mice	  were	  exposed	  daily	  to	  a	  concentration	  of	  
approximately	  1	  mg/m3	  of	  tobacco	  smoke	  for	  6	  h/day.	  Research	  cigarettes	  (3R4F,	  
University	  of	  Kentucky)	  were	  burned	  at	  a	  rate	  of	  two	  cigarettes	  every	  10	  min	  with	  a	  puff	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volume	  of	  35	  mL	  over	  2	  s,	  once	  per	  minute.	  Both	  sidestream	  and	  mainstream	  cigarette	  
smoke	  were	  collected	  via	  a	  chimney	  and	  passed	  to	  a	  dilution	  and	  aging	  chamber	  to	  achieve	  
the	  target	  concentration	  of	  ETS	  (1.0	  ±	  0.17	  mg/m3).	  The	  carbon	  monoxide	  level	  was	  4.8	  ±	  
0.8	  ppm,	  and	  the	  average	  temperature	  was	  73	  °F.	  
	  Once	  the	  dams	  gave	  birth,	  the	  dams	  and	  pups	  were	  only	  exposed	  to	  only	  FA	  until	  
weaning	  and	  then	  shipped	  to	  the	  University	  of	  Montana	  via	  air.	  Upon	  arriving	  at	  the	  
University	  of	  Montana,	  the	  dams	  and	  the	  offspring	  were	  given	  time	  to	  adjust	  to	  their	  new	  
environment.	  Of	  the	  offspring,	  48	  males	  were	  used	  for	  my	  project	  and	  separated	  to	  receive	  
HDM	  or	  PBS	  innoculations.	  
	  
2.3	  Murine	  Model	  of	  Asthma	  
	  
Figure	  3:	  Experimental	  Model	  and	  Timeline.	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A	  house	  dust	  mite	  murine	  model	  of	  airway	  disease	  was	  used	  to	  investigate	  the	  effect	  
of	  prenatal	  ETS	  exposure	  on	  increased	  risk	  or	  exacerbation	  of	  Th2-­‐mediated	  pulmonary	  
inflammation	  and	  AHR.	  There	  are	  several	  species	  of	  HDM,	  however	  only	  two	  are	  known	  to	  
elicit	  an	  allergic	  response,	  one	  of	  which	  is	  Dermatophagoides	  pteronyssinus	  (DerP).	  The	  
exoskeletons	  of	  DerP	  were	  mashed	  and	  suspended	  in	  PBS	  at	  various	  doses	  to	  be	  
administered	  intranasally.	  Male	  offspring	  (6	  weeks	  old)	  were	  sensitized	  and	  challenged	  to	  
HDM	  allergen	  over	  a	  period	  of	  2	  weeks	  by	  intranasal	  administration	  of	  HDM	  (or	  PBS	  
control)	  on	  day	  0	  (100	  μg)	  and	  days	  7	  and	  14	  (50	  μg),	  as	  previously	  described	  (Hammad	  et	  
al.,	  2009).	  On	  day	  16,	  48	  hours	  after	  last	  exposure,	  mice	  were	  harvested	  and	  blood,	  BAL	  
fluid	  and	  lung	  tissue	  were	  collected	  for	  analysis	  of	  allergen-­‐induced	  pulmonary	  
inflammation	  and	  epigenetic	  studies.	  	  
	  
2.4	  Gene	  Specific	  Methylation	  Analysis	  
In	  order	  to	  measure	  methylation	  levels,	  the	  pyrosequencing	  assay	  was	  used	  for	  
selected	  gene-­‐specific	  methylation.	  Genomic	  DNA	  will	  be	  extracted	  from	  murine	  lung	  
samples	  according	  to	  the	  manufacturer’s	  protocol	  included	  with	  the	  DNeasy	  Blood	  &	  Tissue	  
Kit	  (Qiagen).	  
	  
2.4.1	  Primer	  Design	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   Gene	  specific	  murine	  primers	  were	  designed	  for	  Ifn-­‐γ,	  Foxp3,	  Il-­‐4	  and	  Il-­‐13	  using	  
PyroMark	  Assay	  Design	  2.0	  software	  (Qiagen).	  Primers	  were	  designed	  for	  analyzing	  2	  CpGs	  
within	  the	  promoter	  regions.	  
	   Figure	  4	  illustrates	  the	  CpG	  content	  of	  the	  1000	  bp	  promoter	  region,	  with	  the	  red	  
bar	  representing	  the	  region	  analyzed	  by	  pyrosequencing.	  The	  Y	  locations	  represent	  each	  
CpG	  location.	  In	  order	  to	  design	  the	  primer,	  CpG	  islands	  located	  in	  the	  promoter	  region	  
(500-­‐1000	  bp	  upstream	  of	  start	  codon)	  are	  highlighted	  and	  the	  location	  on	  the	  gene	  is	  
denoted.	  Gene	  regions	  were	  located	  using	  NCBI	  and	  GenBank.	  Next,	  the	  sequence	  was	  input	  
into	  Qiagen’s	  Assay	  Design	  Software	  2.0,	  which	  converted	  the	  original	  promoter	  sequence	  
to	  represent	  bisulfite	  converted	  DNA.	  Then,	  a	  region	  of	  interest	  (100-­‐150	  bp	  in	  length)	  was	  
selected	  highlighting	  a	  minimum	  of	  2	  CpG	  locations.	  After	  a	  region	  of	  interest	  was	  selected	  
the	  software	  designs	  the	  forward,	  reverse,	  and	  sequencing	  primers,	  noting	  which	  primer	  is	  
biotinylated,	  and	  assigned	  each	  primer	  set	  a	  score.	  For	  this	  project,	  no	  primer	  score	  below	  
75	  was	  accepted.	  Table	  1	  lists	  the	  promoter	  regions	  of	  the	  genes	  used	  in	  the	  project.	  Table	  2	  
lists	  the	  primers	  designed	  for	  this	  project.	  
	  
Figure	  4:	  CpG	  content	  and	  region	  of	  interest	  within	  gene	  promoter	  region	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Table	  1:	  Murine	  gene	  promoter	  regions	  used	  for	  primer	  design	  
	  
Table	  2:	  Murine	  gene	  specific	  primers	  for	  methylation	  analysis	  
	  
2.4.2	  Bisulfite	  Treatment,	  PCR,	  &	  Pyrosequencing	  	  
	   For	  the	  pyrosequencing	  assay,	  50	  ng	  of	  purified	  DNA	  was	  processed	  by	  bisulfite	  
treatment	  using	  the	  EZ	  DNA	  MethylationTM	  Kit	  (Zymo	  Research).	  PCR	  for	  the	  new	  primer	  
sets	  were	  optimized	  and	  amplification	  was	  verified	  using	  gel	  electrophoresis.	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PCR	  amplification	  of	  the	  50ng	  of	  bisulfite	  converted	  DNA	  was	  conducted	  and	  PCR	  
reactions	  were	  performed	  using	  Pyromark	  PCR	  Kit	  (Qiagen,	  Valencia)	  with	  cycling	  
parameters	  consisting	  of	  denaturation	  at	  95°C	  for	  5	  min,	  and	  45	  cycles	  of	  95°C	  for	  30	  s,	  51-­‐
53°C	  for	  30	  s,	  72°C	  for	  30	  s	  and	  a	  final	  extension	  of	  72°C	  for	  5	  min,	  with	  the	  annealing	  
temperature	  varying	  slightly	  for	  each	  gene-­‐specific	  primer	  set.	  Each	  set	  of	  amplifications	  
will	  include	  CpGenome	  universal	  100%	  methylated	  mouse	  DNA.	  	  
Following	  amplification,	  the	  biotinylated	  PCR	  products	  was	  purified	  and	  incubated	  
with	  the	  sequencing	  primer	  designed	  to	  bind	  adjacent	  to	  the	  CpG	  sites	  of	  interest.	  
Pyrosequencing	  was	  conducted	  using	  a	  PyroMark	  Q96	  MD	  instrument	  (Qiagen),	  with	  
subsequent	  quantification	  of	  methylation	  levels	  determined	  by	  the	  PyroMark-­‐CpG	  
software.	  Relative	  peak	  height	  differences	  were	  used	  to	  calculate	  the	  percentage	  of	  
methylated	  cytosines	  at	  each	  given	  site.	  Percent	  methylation	  within	  a	  sample	  was	  
subsequently	  determined	  by	  averaging	  across	  all	  interrogated	  CpG	  sites	  in	  the	  analysis.	  
Non-­‐CpG	  cytosine	  residues	  were	  used	  as	  internal	  controls	  to	  verify	  efficient	  sodium	  
bisulfite	  DNA	  conversion.	  
	  
2.4.3	  Pyrosequencing	  Data	  Analysis	  
Prenatal	  ETS	  exposures	  and	  DNA	  methylation	  outcomes	  among	  offspring	  were	  also	  
assessed.	  Quantitative	  percent	  changes	  in	  methylation	  were	  evaluated	  as	  a	  continuous	  
dependent	  variable.	  T-­‐test	  was	  used	  to	  examine	  the	  difference	  of	  methylation	  levels	  
between	  ETS	  exposed	  and	  sham	  exposed	  groups.	  The	  difference	  of	  methylation	  levels	  by	  
exposure	  status	  to	  ETS	  as	  well	  as	  asthma	  induction	  by	  HDM	  exposure	  was	  examined	  using	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a	  two-­‐way	  analysis	  of	  variance	  (ANOVA)	  followed	  by	  appropriate	  post	  hoc	  test	  to	  
compensate	  for	  increased	  type	  I	  error.	  ETS	  exposure	  was	  considered	  separately	  and	  
evaluated	  for	  associations	  using	  linear	  regression	  for	  each	  gene	  (i.e.,	  CpG	  promoter	  regions	  
for	  IL-­‐4).	  Two-­‐tailed	  statistical	  significance	  was	  defined	  as	  a	  probability	  of	  type	  I	  error	  
occurring	  at	  less	  than	  5%	  (P	  <	  0.05).	  	  Statistical	  power	  was	  greater	  than	  80%	  (0.8).	  
Statistical	  analysis	  was	  performed	  using	  PRISM	  5.0.	  	  
	  
2.5	  Immunological	  Assays	  
	   Bronchoalveolar	  lavage	  was	  performed	  (3	  ×	  0.5	  ml	  PBS)	  to	  collect	  BAL	  fluid	  for	  
analysis.	  BAL	  fluid	  was	  centrifuged,	  the	  cells	  were	  used	  for	  cell	  differential	  count	  and	  the	  
supernatants	  were	  used	  for	  cytokine	  analysis.	  
	  
	  
2.5.1.	  Measurement	  of	  Cytokines	  
MSD	  Cytokine	  Analysis	  
MSD,	  or	  Meso	  Scale	  Discovery,	  detects	  cytokines	  similarly	  to	  ELISA	  but	  is	  based	  on	  
MULTI-­‐ARRAY®	  technology,	  a	  proprietary	  combination	  of	  electrochemiluminescence	  
detection	  and	  patterned	  arrays.	  Electrochemiluminescence	  detection	  uses	  labels	  that	  emit	  
light	  when	  electrochemically	  stimulated.	  Background	  signals	  are	  minimal	  because	  the	  
stimulation	  mechanism	  (electricity)	  is	  decoupled	  from	  the	  signal	  (light)	  .	  	  
The	  level	  of	  10	  different	  cytokines	  in	  mouse	  BAL	  fluid	  was	  measured.	  Training	  on	  
the	  use	  of	  the	  QuickPlex	  SQ	  120	  instrument	  and	  the	  MSD	  Workbench	  software	  was	  also	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completed.	  The	  MSD	  Mouse	  V-­‐Plex	  Pro-­‐Inflammatory	  Panel	  1	  (MSD)	  was	  used	  and	  
cytokines	  IFN-­‐γ,	  IL-­‐1β,	  IL-­‐10,	  IL-­‐12	  p70,	  IL-­‐2,	  IL-­‐4,	  IL-­‐5,	  IL-­‐6,	  KC/GRO,	  TNF-­‐α	  were	  
measured.	  The	  dynamic	  range	  of	  all	  of	  the	  assays	  was	  3.5-­‐4+	  logs,	  with	  sensitivities	  in	  the	  
10s	  to	  100s	  of	  fg/mL	  for	  most	  assays.	  	  
	  
IL-­‐13	  ELISA	  
IL-­‐13	  was	  measured	  in	  the	  BAL	  fluid	  using	  the	  Quantikine	  ELISA	  kit	  (R&D).	  
	  
2.5.2	  Cell	  Differential	  Count	  
Also	  from	  the	  bronchoalveolar	  lavage,	  cytospin	  preparations	  were	  performed	  on	  
5x104	  BAL	  fluid	  cells	  after	  staining	  the	  cells	  using	  a	  Wright-­‐Giemsa-­‐protocol	  (Hema	  3	  
Staining	  kit,	  Fisher	  Scientific,	  Houston,	  TX).	  Cell	  differential	  percentages	  were	  determined	  
by	  light	  microscopic	  evaluation	  of	  stained	  cells	  and	  expressed	  as	  absolute	  cell	  numbers.	  
	  
2.5.3	  Serum	  IgE	  Analysis	  
	   Blood	  was	  collected	  via	  cardiac	  bleed	  and	  samples	  were	  allowed	  to	  sit	  on	  ice	  for	  20	  
minutes	  after	  collection.	  Samples	  were	  centrifuged	  at	  14000	  RPM	  for	  10	  minutes.	  Serum	  
fraction	  was	  collected,	  making	  an	  effort	  not	  to	  disturb	  the	  pellet.	  Samples	  were	  stored	  in	  -­‐
20°C	  until	  ready	  to	  do	  ELISA.	  Serum	  samples	  were	  analyzed	  at	  a	  1:4	  dilution	  using	  
BioLegend	  IgE	  ELISA	  kit.	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2.5.4	  Data	  Analysis	  
	  	   The	  significance	  of	  the	  differences	  between	  the	  ETS	  and/or	  HDM	  exposure	  groups	  
was	  determined	  by	  t-­‐test,	  one-­‐way,	  or	  two-­‐way	  ANOVA,	  in	  conjunction	  with	  post	  hoc	  test	  
for	  variance,	  where	  appropriate.	  Graphics	  and	  analyses	  were	  performed	  on	  SPSS	  or	  Prism	  
software,	  version	  5	  (GraphPad,	  La	  Jolla,	  CA),	  depending	  on	  the	  complexity	  of	  the	  design.	  
The	  criterion	  for	  significance	  was	  set	  at	  P	  <	  0.05.	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3.1	  Specific	  Aim	  1:	  Epigenetic	  Alterations	  
In	  allergic	  airway	  hyperactivity,	  a	  Th2	  response	  is	  favored	  and	  inhibits	  both	  Th1	  and	  
Treg	  responses.	  In	  order	  to	  illustrate	  a	  Th2	  bias	  the	  methylation	  level	  of	  multiple	  murine	  
genes	  were	  assessed.	  In	  particular,	  we	  assessed	  the	  promoter	  regions	  of	  murine	  genes	  Il-­‐4	  
and	  Il-­‐13,	  which	  when	  expressed	  allow	  for	  production	  of	  cytokines	  heavily	  involved	  in	  the	  
Th2	  response.	  In	  order	  to	  illustrate	  a	  lack	  of	  a	  Th1	  response,	  the	  methylation	  of	  murine	  
gene	  Ifn-­‐γ,	  which	  translates	  into	  a	  Th1	  cytokine,	  was	  also	  assessed.	  Lastly,	  the	  promoter	  
methylation	  of	  a	  representative	  gene	  that	  translates	  into	  regulatory	  molecules,	  or	  Treg	  
cells,	  Foxp3	  was	  assessed.	  In	  order	  to	  perform	  the	  methylation	  analysis,	  DNA	  was	  isolated	  
from	  murine	  lungs	  and	  after	  bisulfite	  treatment	  was	  amplified	  with	  gene-­‐specific	  primers	  
and	  the	  methylation	  was	  analyzed	  via	  pyrosequencing.	  
	  
3.1.1	  Genes	  representing	  Th2	  bias	  
Il-­‐4	   	  
Il-­‐4	  is	  a	  murine	  gene	  that,	  when	  expressed,	  produces	  pro-­‐allergic	  cytokine	  IL-­‐4.	  IL-­‐4	  
is	  a	  multi-­‐functional	  cytokine	  involved	  in	  Th2	  cell	  differentiation	  and	  also	  in	  eosinophil	  
recruitment	  (Bloemen	  et	  al.	  2007).	  The	  promoter	  methylation	  of	  the	  gene	  Il-­‐4	  was	  analyzed	  
in	  order	  to	  determine	  if	  prenatal	  ETS	  exposure	  altered	  methylation	  patterns	  of	  this	  pro-­‐
allergic	  gene.	  Figure	  5	  shows	  significant	  hypomethylation	  of	  the	  HDM	  group	  when	  
compared	  to	  the	  PBS	  exposed	  group	  (65.33%	  +/-­‐	  0.95	  vs.	  68.57%	  +/-­‐	  0.68,	  respectively).	  
Significant	  hypomethylation	  was	  also	  observed	  when	  adjusting	  for	  prenatal	  ETS	  exposure	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Figure	  5:	  Il-­‐4	  hypomethylation	  after	  prenatal	  ETS	  exposure.	  Il-­‐4	  is	  significantly	  
hypomethylated	  in	  the	  HDM	  exposed	  groups	  and	  is	  also	  hypomethylated	  further	  if	  exposed	  
prenatally	  to	  ETS.	  Two-­‐tailed	  ANOVA	  with	  Bonferonni	  Post-­‐Hoc	  tests.	  Data	  are	  means	  +/-­‐	  







































Il-­‐13	   	  
Murine	  gene	  Il-­‐13	  translates	  to	  the	  asthma-­‐related	  cytokine	  IL-­‐13.	  IL-­‐13	  is	  crucial	  
for	  eosinophil	  recruitment	  and	  is	  secreted	  primarily	  by	  Th2	  cells.	  Figure	  6	  shows	  a	  trend	  of	  
hypomethylation,	  but	  no	  significant	  difference	  of	  the	  PBS	  group	  when	  compared	  to	  the	  
HDM	  exposed	  group	  (68.12%	  +/-­‐	  0.79	  vs.	  67.33%	  +/-­‐	  0.37,	  respectively).	  No	  significant	  
hypomethylation	  was	  also	  observed	  when	  adjusting	  for	  prenatal	  ETS	  exposure	  (FA:	  
66.96%	  +/-­‐	  0.48	  vs.	  ETS:	  67.78%	  +/-­‐	  0.26).	  
	  
	   	  	  
Figure	  6:	  Il-­‐13	  methylation	  results.	  Il-­‐13	  is	  not	  significantly	  hypomethylated	  in	  the	  HDM	  
exposed	  group,	  but	  shows	  a	  hypomethylation	  trend.	  No	  significance	  is	  found	  when	  adjusting	  
for	  prenatal	  ETS	  exposure.	  Two-­‐tailed	  ANOVA	  with	  Bonferonni	  Post-­‐Hoc	  tests.	  Data	  are	  
































3.1.2	  Gene	  representing	  Th1	  response	  
Ifn-­‐γ	  
Methylation	  results	  are	  displayed	  in	  Figure	  7.	  The	  methylation	  levels	  show	  
significant	  hypermethylation	  of	  the	  HDM	  group	  when	  compared	  to	  the	  PBS	  exposed	  group	  
(70.18%	  +/-­‐	  0.69	  vs.	  72.92%	  +/-­‐	  0.90,	  respectively).	  Significant	  hypermethylation	  was	  also	  




Figure	  7:	  Hypermethylation	  of	  Ifn-­‐γ	  after	  HDM	  and	  prenatal	  ETS	  exposure.	  Ifn-­‐γ	  was	  
significantly	  hypermethylated	  in	  the	  HDM	  exposed	  groups	  and	  is	  hypermethylated	  further	  if	  
exposed	  prenatally	  to	  ETS.	  Two-­‐tailed	  ANOVA	  with	  Bonferonni	  Post-­‐Hoc	  tests.	  Data	  are	  means	  



































3.1.3	  Gene	  representing	  Regulatory	  Response	  
Foxp3	  
Figure	  8	  shows	  no	  significant	  difference	  in	  methylation	  levels	  in	  any	  exposure	  
group.	  	  There	  is	  a	  no	  trend	  of	  hypermethylation	  when	  comparing	  PBS	  groups	  to	  HDM	  group	  
(79.25%	  +/-­‐	  0.85	  vs.	  79.58%	  +/-­‐	  1.02).	  Nor	  is	  there	  a	  difference	  when	  adjusting	  for	  
prenatal	  ETS	  exposure	  (FA:	  80.17%	  +/-­‐	  1.05	  vs.	  ETS:	  78.98	  +/-­‐	  1.27).	  
	  
	  
Figure	  8:	  Foxp3	  methylation	  results.	  The	  methylation	  levels	  of	  the	  promoter	  region	  of	  
Foxp3	  are	  not	  significantly	  different	  between	  the	  groups.	  Two-­‐tailed	  ANOVA	  with	  Bonferonni	  



































3.2	  Specific	  Aim	  2:	  Immunological	  Responses	  
	   In	  order	  to	  determine	  if	  prenatal	  ETS	  exposure	  increased	  susceptibility	  to	  allergic	  
airway	  disease	  pro-­‐allergic	  cytokines,	  inflammatory	  cell	  numbers,	  and	  serum	  IgE	  were	  
analyzed.	  The	  cytokines	  IL-­‐4,	  IL-­‐5,	  and	  IL-­‐13	  were	  analyzed	  in	  BAL	  fluid	  in	  order	  to	  
determine	  if	  Th2	  polarization	  was	  taking	  place,	  as	  these	  cytokines	  play	  a	  huge	  role	  in	  T-­‐cell	  
differentiation	  and	  the	  Th2	  response.	  IFN-­‐γ	  was	  also	  measured	  in	  the	  BAL	  fluid	  to	  
determine	  the	  Th1	  response,	  or	  lack	  thereof.	  In	  addition	  to	  cytokine	  measurement,	  
inflammatory	  cell	  types	  were	  determined	  in	  order	  to	  distinguish	  an	  allergic	  response	  or	  
inflammatory	  response.	  To	  further	  support	  the	  data,	  IgE	  levels	  in	  the	  serum	  were	  evaluated	  
to	  determine	  the	  extent	  of	  allergic	  response	  present.	  
	  
3.2.1	  Cytokine	  Analysis	  
IL-­‐4	  
IL-­‐4	  is	  a	  very	  important	  cytokine,	  it	  not	  only	  is	  produced	  and	  released	  by	  Th2	  cells,	  
but	  also	  plays	  a	  role	  in	  differentiating	  naïve	  T-­‐cells	  (Bloemen	  et	  al.	  2007).	  IL-­‐4	  plays	  a	  role	  
in	  eosinophil	  recruitment	  and	  infiltration	  and	  also	  is	  secreted	  by	  eosinophils	  in	  order	  to	  
create	  a	  positive	  feedback	  loop	  (Kay	  et	  al.	  1997).	  To	  determine	  the	  susceptibility	  to	  allergic	  
airway	  hyperreactivity	  after	  prenatal	  ETS	  exposure,	  IL-­‐4	  was	  measured	  in	  the	  BAL	  fluid	  by	  
QuickPlex	  SQ	  120	  instrument	  and	  the	  MSD	  Workbench	  software	  using	  the	  MSD	  Mouse	  V-­‐
Plex	  Pro-­‐Inflammatory	  Panel	  1.	  Our	  results	  show	  that	  IL-­‐4	  was	  not	  produced	  in	  the	  PBS	  





Figure	  9:	  Increased	  production	  of	  IL-­‐4	  after	  prenatal	  ETS	  exposure	  and	  HDM	  challenge.	  
IL-­‐4	  was	  significantly	  increased	  in	  BAL	  fluid	  of	  mice	  exposed	  prenatally	  to	  ETS	  and	  challenged	  












IL-­‐5	  is	  a	  critical	  cytokine	  in	  allergic	  airway	  disease	  and	  asthma.	  It	  is	  secreted	  
primarily	  by	  Th2	  cells	  but	  also	  by	  mast	  cells.	  	  IL-­‐5	  stimulates	  immunoglobulin	  secretion	  by	  
B	  cells	  and	  is	  also	  a	  key	  mediator	  in	  eosinophil	  activation,	  along	  with	  IL-­‐13(Bloemen	  et	  al.	  
2007;	  Kay	  et	  al.	  1997).	  	  To	  determine	  the	  susceptibility	  to	  allergic	  airway	  hyperreactivity	  
after	  prenatal	  ETS	  exposure,	  IL-­‐5	  was	  measured	  in	  the	  BAL	  fluid	  by	  QuickPlex	  SQ	  120	  
instrument	  and	  the	  MSD	  Workbench	  software	  using	  the	  MSD	  Mouse	  V-­‐Plex	  Pro-­‐
Inflammatory	  Panel	  1.	  Our	  results	  show	  that	  IL-­‐5	  was	  produced	  in	  small	  quantities	  in	  the	  
















Figure	  10.	  IL-­‐5	  production	  increased	  after	  prenatal	  ETS	  exposure	  and	  HDM	  challenge.	  
IL-­‐5	  was	  significantly	  increased	  in	  BAL	  fluid	  of	  mice	  exposed	  prenatally	  to	  ETS	  and	  challenged	  










IL-­‐13	   	  
IL-­‐13,	  as	  well	  as	  other	  Th2	  cytokines,	  plays	  an	  important	  role	  in	  the	  remodeling	  
process	  and suspected	  to	  be	  central	  mediator	  of	  physiologic	  changes	  induced	  by	  allergic	  
inflammation	  in	  airway	  epithelium.	  In	  order	  to	  determine	  if	  HDM	  and	  prenatal	  ETS	  
exposure	  influenced	  the	  allergic	  response,	  BAL	  fluid	  was	  analyzed	  for	  the	  cytokine	  Il-­‐13	  via	  
ELISA.	  Without	  HDM	  exposure,	  no	  IL-­‐13	  was	  produced,	  and	  with	  HDM	  exposure,	  the	  
animals	  with	  prenatal	  ETS	  exposure	  had	  significantly	  increased	  IL-­‐13	  production	  (FA:	  6.56	  













Figure	  11:	  Increased	  Il-­‐13	  production	  in	  prenatally	  ETS	  exposed	  group	  with	  HDM	  
challenge.	  Il-­‐13	  was	  significantly	  increased	  in	  BAL	  fluid	  of	  mice	  exposed	  prenatally	  to	  ETS	  











































IFN-­‐γ	  is	  a	  cytokine	  that	  is	  critical	  for	  both	  innate	  and	  adaptive	  immunity	  to	  protect	  
the	  system	  against	  bacterial	  and	  viral	  infections.	  IFNγ	  is	  secreted	  by	  Th1	  cells	  and	  is	  an	  
important	  activator	  of	  macrophages	  (Bloemen	  et	  al.	  2007).	  When	  IFN-­‐γ	  is	  present	  Th1	  cells	  
inhibit	  many	  Th2-­‐induced	  effector	  functions	  that	  allergic	  airway	  disease.	  It	  has	  also	  been	  
found	  that	  the	  action	  of	  IFN-­‐γ	  through	  the	  airway	  epithelium	  will	  limit	  airway	  obstruction	  
and	  inflammation	  (Mitchell	  et	  al.	  2011).	  To	  determine	  the	  susceptibility	  to	  allergic	  airway	  
hyperreactivity	  after	  prenatal	  ETS	  exposure	  and	  determine	  if	  Th2	  polarization	  was	  taking	  
place,	  IFN-­‐γ	  was	  measured	  in	  the	  BAL	  fluid	  by	  QuickPlex	  SQ	  120	  instrument	  and	  the	  MSD	  
Workbench	  software	  using	  the	  MSD	  Mouse	  V-­‐Plex	  Pro-­‐Inflammatory	  Panel	  1.	  Our	  results	  
indicated	  that	  there	  was	  little	  to	  no	  production	  of	  IFN-­‐γ	  in	  any	  of	  the	  exposure	  groups.	  IFN-­‐













Figure	  12:	  IFN-­‐γ	  production	  in	  BAL	  fluid.	  There	  was	  little	  production	  of	  IFN-­‐γ	  for	  all	  of	  the	  











3.2.2	  Absolute	  inflammatory	  cell	  number	  
During	  the	  inflammatory	  process,	  infiltration	  of	  inflammatory	  cells	  occurs	  in	  
airways	  and	  eosinophil	  infiltration	  in	  airways	  is	  a	  hallmark	  of	  airway	  inflammation.	  
Eosinophil	  infiltration	  is	  initiated	  by	  the	  secretion	  of	  Th2	  cytokines	  IL-­‐4,	  IL-­‐5,	  and	  IL-­‐13	  
(Bloemen	  et	  al.	  2007).	  In	  order	  to	  evaluate	  whether	  our	  prenatal	  ETS	  exposure	  increases	  
airway	  inflammation,	  absolute	  cell	  numbers	  in	  BAL	  fluid	  were	  determined.	  Figure	  13	  
demonstrates	  that	  the	  HDM	  exposure	  induced	  eosinophil	  production	  (59546	  +/-­‐	  2153	  for	  
FA	  +	  HDM	  vs.	  0	  for	  FA	  +PBS)	  and	  this	  effect	  was	  increased	  by	  prenatal	  ETS	  exposure	  
(94278	  +/-­‐	  6277	  for	  Pre	  ETS	  +HDM	  vs.	  59546	  +/-­‐	  2153	  for	  FA	  +	  HDM).	  No	  significant	  
increase	  in	  cell	  numbers	  for	  lymphocytes,	  macrophages,	  or	  neutrophils	  was	  observed.	  
	  
	  
	   Figure	  13.	  HDM	  and	  Prenatal	  ETS	  exposure	  increase	  eosinophils	  in	  BAL	  fluid.	  This	  
figure	  represents	  total	  inflammatory	  cell	  count.	  Data	  are	  means	  ±	  SEM	  n=3.	  ***	  indicates	  P	  
values	  <	  0.001	  compared	  to	  FA	  +HDM	  group.	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3.2.3	  Serum	  IgE	  
Atopy,	  or	  increased	  levels	  of	  IgE	  in	  the	  blood,	  is	  a	  strong	  risk	  factor	  for	  developing	  
allergic	  asthma.	  To	  determine	  whether	  prenatal	  ETS	  exposure	  affects	  atopy,	  IgE	  levels	  in	  
the	  mouse	  serum	  were	  measured	  by	  ELISA.	  Our	  results	  indicate	  that,	  with	  exception	  of	  two	  




Figure	  14.	  Serum	  levels	  of	  IgE.	  IgE	  levels	  were	  not	  significantly	  increased	  among	  the	  
different	  exposure	  groups,	  with	  the	  exception	  of	  two	  outliers.	  Data	  represented	  are	  individuals	  







































Allergic	  asthma	  is	  a	  chronic	  disease,	  which	  is	  increasing	  in	  diagnoses	  each	  year,	  
especially	  among	  children(Eder	  et	  al.	  2006).	  The	  mechanism	  for	  this	  disease	  has	  yet	  to	  be	  
elucidated,	  although	  epigenetic	  changes	  have	  been	  introduced	  as	  a	  possible	  mechanism	  for	  
this	  debilitating	  disease.	  Allergic	  asthma	  is	  usually	  exacerbated	  after	  multiple	  exposures	  to	  
allergens	  or	  environmental	  pollutants,	  such	  as	  tobacco	  smoke,	  PAHs,	  pollen	  and	  house	  dust	  
mite	  (HDM)	  (Bégin	  &	  Nadeau	  2014).	  In	  urban	  areas,	  HDM	  is	  one	  of	  the	  most	  common	  
allergens.	  It	  has	  been	  suggested	  that	  chronic	  exposure	  to	  HDM	  skeletal	  extracts	  induces	  
airway	  remodeling	  and	  AHR	  via	  allergic	  immune	  responses.	  It	  has	  been	  proposed	  that	  HDM	  
extracts	  can	  destroy	  airway	  epithelial	  and	  ASM	  cells	  by	  its	  proteolytic	  activity	  (Grunstein	  et	  
al.	  2005).	  In	  the	  experimental	  murine	  model	  of	  asthma,	  previous	  studies	  found	  an	  increase	  
in	  Th2	  cytokine	  levels	  and	  the	  numbers	  of	  inflammatory	  cells	  in	  response	  to	  HDM	  (Jaffar	  et	  
al.	  1999),	  illustrating	  that	  the	  HDM	  methodology	  represents	  an	  accurate	  allergen	  induced	  
murine	  model	  of	  airway	  hyperreactivity.	  
	   There	  is	  an	  agreement	  that	  epigenetic	  regulation	  can	  be	  altered	  with	  environmental	  
exposure	  and	  its	  dysregulation	  leads	  to	  asthma	  pathogenesis	  and	  susceptibility	  (S.-­‐C.	  Wang	  
et	  al.	  2008;	  Miller	  &	  Ho	  2008;	  Ho	  2010).	  Increased	  DNA	  methylation	  (hypermethylation)	  
within	  the	  CpG	  islands	  in	  promoter	  regions	  of	  genes	  alters	  gene	  transcription	  machinery	  
and	  eventually	  leads	  to	  decreases	  in	  gene	  expression.	  Conversely,	  decreased	  methylation	  
(hypomethylation)	  can	  lead	  to	  an	  increase	  in	  gene	  expression.	  Gene	  dysregulation	  further	  
affects	  cellular	  functions.	  Global	  DNA	  methylation	  levels	  assayed	  by	  methylation	  sensitive	  
pyrosequencing	  or	  PCR	  of	  the	  repetitive	  elements	  LINE-­‐1	  and	  Alu	  have	  been	  found	  to	  be	  
	  45	  
decreased	  in	  response	  to	  prenatal	  tobacco	  smoke	  (Breton	  et	  al.	  2009).	  In	  this	  study,	  
reduced	  global	  DNA	  methylation	  was	  associated	  with	  an	  increased	  risk	  of	  childhood	  
asthma.	  Genomic	  DNA	  methylation,	  however,	  are	  not	  indicative	  of	  transcription	  level	  
mechanisms	  that	  are	  occurring	  which	  may	  be	  altering	  asthma	  susceptibility.	  In	  order	  to	  
illustrate	  the	  relationship	  between	  allergic	  asthma	  and	  DNA	  methylation	  we	  analyzed	  the	  
gene-­‐specific	  methylation,	  via	  pyrosequencing,	  of	  the	  promoter	  regions	  of	  asthma-­‐
associated	  genes.	  According to multiple studies, asthma related genes such as, IL-4,	  Il-­‐13,	  
IFN-­‐	  γ,	  and	  Foxp3	  have	  all	  been	  shown	  to	  be	  epigenetically	  regulated(Lee	  et	  al.	  2002;	  Lu	  et	  
al.	  2009;	  White	  et	  al.	  2006;	  Huehn	  et	  al.	  2009).	  In	  order	  to	  determine	  if	  these	  genes	  were	  
epigenetically	  regulated	  in	  our	  murine	  model	  of	  asthma,	  gene	  specific	  primers	  for	  these	  
four	  genes	  were	  designed,	  as	  no	  murine	  primers	  for	  pyrosequencing	  analysis	  of	  the	  
promoter	  regions	  of	  these	  genes	  have	  been	  published.	  However,	  there	  are	  publications	  
illustrating	  the	  relationship	  of	  various	  epigenetic	  mechanisms	  in	  allergic	  disease,	  and	  also	  
studies	  demonstrating	  how	  global	  methylation	  if	  affected	  by	  HDM	  and	  tobacco	  smoke	  
exposure	  (Cheng	  et	  al.	  2014).	  Currently,	  there	  are	  no	  published	  studies	  showing	  the	  
relationship	  between	  altered	  gene-­‐specific	  methylation	  levels	  after	  HDM	  or	  ETS	  exposure	  
with	  correlation	  to	  immunological	  responses.	  	  The	  novelty	  of	  this	  project	  lies	  in	  having	  a	  
known	  ETS	  exposure	  dose,	  an	  efficient	  model	  of	  murine	  allergic	  airway	  hyperreactivity,	  
and	  pyrosequencing	  technology	  to	  determine	  gene	  specific	  methylation	  of	  asthma-­‐
associated	  genes.	  
	   Il-­‐4	  plays	  an	  important	  role	  in	  naïve	  T-­‐cell	  differentiation	  and	  Th2	  polarization	  
during	  an	  allergic	  response.	  Human	  studies	  have	  concluded	  that	  naive	  CD4+	  T	  cells	  are	  
hypermethylated	  at	  the	  5’	  end	  of	  the	  IL-­‐4	  gene	  as	  well	  as	  in	  the	  intergenic	  IL-­‐4/IL-­‐13	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region.	  	  Then,	  after	  Th2	  differentiation	  they	  found	  these	  regions	  to	  be	  demethylated,	  
suggesting	  an	  increase	  in	  expression	  of	  these	  genes	  (Lee	  et	  al.	  2002).	  Alterations	  in	  these	  
methylation	  patterns	  could	  affect	  how	  the	  naïve	  CD4+	  T	  cells	  differentiate,	  and	  certain	  
exposures	  may	  trigger	  these	  methylation	  patterns.	  Whether	  these	  methylation	  patterns	  
could	  be	  altered	  after	  prenatal	  exposure	  to	  ETS	  is	  yet	  to	  be	  determined.	  Our	  study	  shows	  
significant	  hypomethylation	  of	  Il-­‐4	  in	  lung	  DNA	  of	  prenatally	  ETS	  exposed	  mice	  after	  being	  
challenged	  with	  HDM,	  which	  suggests	  that	  the	  gene	  would	  be	  up-­‐regulated,	  and	  
transcription	  of	  Il-­‐4	  increased.	  	  
Il-­‐13	  is	  also	  very	  important	  for	  Th2	  polarization	  and	  the	  Th2	  response,	  however	  we	  
did	  not	  see	  a	  significant	  difference	  in	  the	  methylation	  patterns	  of	  the	  Il-­‐13	  gene.	  
Publications	  have	  shown	  Il-­‐13	  to	  be	  epigenetically	  regulated,	  but	  by	  a	  different	  epigenetic	  
mechanism	  known	  as	  microRNA	  (Lu	  et	  al.	  2009).	  Therefore,	  it	  could	  be	  possible	  that	  Il-­‐13	  
may	  not	  be	  epigenetically	  regulated	  by	  DNA	  methylation	  mechanisms.	  Also,	  many	  different	  
cell	  types,	  such	  as	  eosinophils,	  macrophages,	  dendritic	  cells,	  and	  B-­‐cells	  secrete	  IL-­‐4,	  while	  
only	  fully	  differentiated	  Th2	  cells	  secrete	  IL-­‐13.	  A	  reason	  why	  no	  methylation	  change	  was	  
observed	  could	  be	  because	  the	  DNA	  used	  in	  our	  experiment	  came	  from	  the	  whole	  lung,	  
consisting	  of	  a	  various	  cell	  types.	  It	  may	  be	  possible	  to	  see	  hypomethylation	  in	  Il-­‐13	  if	  
sorting	  for	  the	  Th2	  cells	  within	  the	  lung.	  	  
	   IFN-­‐	  γ	  is	  thought	  to	  be	  highly	  regulated	  early	  in	  life	  and	  epigenetic	  mechanisms	  are	  
theorized	  to	  play	  a	  role	  in	  its	  expression,	  especially	  in	  allergic	  disease	  (White	  et	  al.	  2006).	  
Our	  study	  illustrated	  significant	  hypermethylation	  of	  Ifn-­‐	  γ	  after	  HDM	  challenge	  and	  was	  
further	  hypermethylated	  if	  the	  animal	  experienced	  prenatal	  ETS	  exposure.	  This	  suggests	  
that	  the	  gene	  Ifn-­‐	  γ	  is	  less	  likely	  to	  be	  transcribed	  and	  its	  expression	  would	  be	  down	  
	  47	  
regulated.	  Down-­‐regulated	  expression	  would	  lead	  to	  less	  cytokine	  production.	  In	  our	  
experiment	  we	  did	  not	  see	  production	  of	  IFN-­‐	  γ	  in	  any	  of	  the	  exposure	  groups.	  
	  The	  methylation	  of	  Foxp3,	  which	  is	  a	  transcription	  factor	  that	  is	  expressed	  in	  
important	  regulatory	  T-­‐cells,	  did	  not	  change	  among	  the	  different	  exposure	  groups.	  	  As	  it	  
has	  been	  shown	  that	  FOXP3	  expression	  is	  regulated	  by	  DNA	  methylation	  (Lal	  et	  al.	  2009),	  
we	  expected	  to	  see	  methylation	  differences.	  The	  lack	  of	  methylation	  change	  could	  be	  due	  to	  
the	  fact	  that	  the	  cells	  expressing	  this	  transcription	  factor	  would	  be	  a	  small	  subset	  of	  the	  
cells	  from	  which	  we	  extracted	  the	  DNA.	  There	  would	  be	  a	  potential	  for	  methylation	  
differences	  if	  T-­‐regulatory	  cells	  were	  sorted,	  which	  would	  warrant	  further	  studies.	  
Taken	  together,	  our	  epigenetic	  results	  suggest	  that	  HDM	  and	  especially	  prenatal	  
exposure	  to	  ETS	  might	  trigger	  gene-­‐specific	  DNA	  methylation	  machinery	  either	  through	  the	  
use	  of	  DNA	  methylation	  transferases,	  hydroxymethylation,	  or	  the	  passive/active	  
demethylation	  via	  DNA	  repair,	  resulting	  in	  altered	  gene	  transcription.	  The	  mechanism	  by	  
which	  these	  epigenetic	  machineries	  contribute	  to	  gene	  transcription	  and	  its	  functions	  in	  
airway	  disease	  remains	  unanswered	  and	  requires	  further	  study.	  As	  the	  field	  of	  epigenetics	  
and	  its	  technology	  advances,	  increased	  knowledge	  and	  new	  validation	  assays	  will	  likely	  
improve	  our	  ability	  to	  reveal	  markers	  for	  the	  prevention,	  diagnosis,	  and	  prognosis	  of	  
asthma.	  	  	  
Th2	  bias,	  eosinophilia,	  and	  AHR	  are	  the	  hallmarks	  of	  allergic	  asthma	  and,	  in	  animal	  
models,	  prenatal	  plus	  perinatal	  exposure	  to	  mainstream	  as	  well	  as	  secondhand	  cigarette	  
smoke	  increases	  AHR	  and	  Th2	  lung	  inflammation	  (Singh	  et	  al.	  2003)	  In	  this	  project,	  we	  
showed	  that	  prenatal	  exposure	  to	  ETS	  primes	  the	  lung	  to	  dramatic	  increases	  in	  allergic	  
	  48	  
airway	  response	  (increased	  eosinophils)	  as	  well	  as	  Th2	  inflammation	  (increased	  IL-­‐4,	  Il-­‐5	  
and	  IL-­‐13)	  levels.	  	  
Production	  of	  Il-­‐4	  is	  significantly	  increased	  in	  BAL	  fluid	  after	  prenatal	  exposure	  to	  
ETS	  and	  challenge	  with	  HDM.	  This	  correlates	  with	  our	  methylation	  data,	  which	  shows	  
significant	  hypomethylation	  in	  the	  ETS	  exposed	  group	  corresponds	  to	  a	  significant	  increase	  
in	  production	  of	  Il-­‐4.	  This	  illustrates	  that	  prenatal	  exposure	  to	  ETS	  could	  illicit	  epigenetic	  
programming,	  making	  the	  ETS-­‐exposed	  mice	  more	  susceptible	  to	  Th2	  polarization	  and	  an	  
allergic	  phenotype	  when	  challenged	  with	  allergen.	  Also,	  the	  promoter	  region	  of	  Ifn-­‐	  γ	  was	  
hypermethylated	  and	  no	  significant	  levels	  of	  IFN-­‐γ	  were	  observed	  in	  the	  BAL	  fluid.	  	  
Production	  of	  Th2	  cytokines	  IL-­‐5	  and	  IL-­‐13	  were	  also	  significantly	  increased	  in	  the	  
BAL	  fluid	  of	  prenatally	  ETS	  exposed	  mice,	  illustrating	  their	  increased	  susceptibility	  to	  
asthma.	  The	  increased	  cytokine	  levels	  of	  IL-­‐4,	  IL-­‐5,	  and	  IL-­‐13	  were	  consistent	  with	  the	  cell	  
differential	  data	  showing	  increased	  production	  of	  eosinophils.	  The	  cytokines	  just	  listed	  are	  
crucial	  for	  the	  recruitment	  of	  eosinophils	  and	  eosinophilia	  is	  a	  hallmark	  trait	  of	  asthmatic	  
individuals(Bloemen	  et	  al.	  2007).	  The	  number	  of	  eosinophils	  significantly	  increased	  in	  the	  
mice	  prenatally	  exposed	  to	  ETS	  and	  challenged	  with	  HDM.	  Unfortunately,	  the	  epigenetic	  
modification	  of	  Il-­‐5	  was	  not	  analyzed	  and	  based	  on	  the	  immunological	  results,	  is	  an	  
experiment	  worth	  pursuing.	  The	  epigenetic	  results	  of	  Il-­‐13,	  however,	  were	  inconclusive	  
and	  did	  not	  support	  the	  hypothesis.	  The	  cytokine	  IL-­‐13	  may	  not	  be	  epigenetically	  regulated	  
as	  its	  transcription	  factors	  are	  activated	  by	  IL-­‐4	  (Bloemen	  et	  al.	  2007),	  however	  further	  
studies	  on	  these	  mechanisms	  need	  to	  be	  completed.	  	  
Serum	  IgE	  level	  of	  the	  mice	  was	  also	  evaluated.	  The	  mice	  in	  this	  experiment,	  with	  
the	  exception	  of	  two	  outliers,	  did	  not	  demonstrate	  to	  have	  increased	  levels	  of	  IgE,	  or	  atopy,	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after	  exposure	  to	  ETS	  or	  to	  HDM.	  The	  normal	  HDM	  protocol	  carried	  out	  by	  Jaffar	  et.	  al.	  is	  a	  3	  
week	  sensitization	  and	  challenge	  protocol,	  after	  which	  all	  of	  the	  HDM	  exposed	  mice	  have	  
severe	  airway	  hyperreactivity	  and	  a	  highly	  allergic	  response	  (Jaffar	  et	  al.	  1999).	  In	  this	  
study,	  in	  an	  effort	  not	  to	  mask	  the	  effect	  of	  ETS,	  the	  mice	  were	  only	  exposed	  to	  HDM	  using	  a	  
2-­‐week	  protocol.	  This	  lessened	  HDM	  exposure	  allowed	  us	  to	  see	  the	  effects	  of	  the	  ETS,	  
however,	  it	  did	  prevent	  eliciting	  a	  severe	  allergic	  response	  which	  would	  correspond	  to	  high	  
serum	  IgE	  levels.	  	  
Our	  study	  also	  had	  various	  limitations.	  Lungs	  acquired	  from	  mice	  are	  very	  small	  and	  
it	  is	  tedious	  and	  difficult	  to	  acquire	  the	  necessary	  amount	  of	  DNA	  from	  sorted	  cell	  
populations,	  such	  as	  Th2	  and	  Treg	  cells.	  Epigenetic	  patterns	  are	  altered	  in	  each	  specific	  cell	  
type,	  so	  by	  extracted	  whole	  lung	  DNA	  we	  are	  diluting	  the	  actual	  methylation	  of	  the	  
promoter	  region	  of	  interest.	  Also,	  in	  order	  to	  conclude	  a	  true	  correlation	  between	  Ifn-­‐γ	  
methylation	  and	  IFN-­‐γ	  production,	  we	  would	  have	  liked	  to	  observe	  a	  decrease	  in	  the	  Th1	  
cytokine	  after	  prenatal	  ETS	  exposure	  and	  HDM	  challenge.	  However,	  since	  all	  results	  were	  
baseline,	  this	  conclusion	  cannot	  be	  made.	  The	  methylation	  level	  across	  all	  groups,	  however,	  
may	  be	  the	  reason	  that	  no	  production	  was	  observed.	  Stress	  is	  another	  factor	  shown	  to	  alter	  
epigenetic	  patterns	  (Pembrey	  et	  al.	  2014).	  Therefore,	  another	  limitation	  is	  that	  the	  mice	  
were	  shipped	  via	  plane	  from	  UC	  Davis	  to	  the	  University	  of	  Montana,	  and	  this	  could	  have	  
stressed	  the	  animals,	  which	  may	  have	  altered	  some	  of	  the	  methylation	  results,	  although	  
these	  changes	  may	  not	  have	  effected	  the	  asthma-­‐associated	  genes	  of	  interest.	  	  
Overall,	  this	  project	  strongly	  suggested	  that	  a	  developing	  fetus	  is	  exceptionally	  
sensitive	  to	  even	  very	  low	  doses	  of	  cigarette	  smoke,	  which	  may	  promote	  the	  development	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and	  increase	  the	  susceptibility	  of	  childhood	  allergic	  asthma.	  Every	  effort	  should	  be	  made	  to	  
























CONCLUSIONS	  AND	  FUTURE	  DIRECTIONS	  
This	  study	  was	  designed	  to	  research	  the	  effect	  of	  prenatal	  ETS	  exposure	  on	  
epigenetic	  programming	  and	  hypothesized	  increased	  susceptibility	  to	  development	  of	  
allergen-­‐induced	  airway	  inflammation.	  In	  order	  to	  complete	  this	  goal,	  I	  used	  a	  HDM	  
allergen-­‐induced	  mouse	  model	  of	  asthma	  to	  examine	  the	  effect	  of	  in	  utero	  ETS	  exposure	  on	  
susceptibility	  to	  an	  asthmatic	  phenotype	  via	  the	  proposed	  mechanism	  of	  epigenetic	  
programming	  by	  alterations	  in	  DNA	  methylation	  of	  genes	  associated	  with	  asthma.	  
	   To	  summarize,	  prenatal	  ETS	  exposure	  altered	  the	  methylation	  of	  the	  promoter	  
regions	  of	  asthma-­‐associated	  genes	  Il-­‐4	  and	  Ifn-­‐	  γ.	  Il-­‐4	  was	  hypomethylated,	  which	  
corresponded	  to	  the	  increased	  production	  of	  IL-­‐4	  that	  was	  found	  in	  the	  BAL	  fluid.	  Ifn-­‐	  γ	  
promoter	  region	  was	  hypermethylated,	  which	  correlated	  in	  there	  being	  little	  to	  no	  
production	  of	  IFN-­‐	  γ	  present	  in	  the	  BAL	  fluid.	  There	  was	  also	  an	  increased	  amount	  of	  IL-­‐13	  
and	  IL-­‐5	  found	  in	  the	  BAL	  fluid	  after	  prenatal	  ETS	  exposure,	  however	  Il-­‐13	  methylation	  
levels	  did	  not	  differ	  among	  groups	  and	  IL-­‐5	  methylation	  levels	  were	  not	  assessed.	  	  
Further	  investigation	  is	  needed	  in	  order	  to	  determine	  if	  there	  is	  perhaps	  another	  
region	  within	  the	  promoter	  of	  Il-­‐13	  where	  the	  methylation	  may	  take	  place	  or	  perhaps	  
looking	  specifically	  at	  the	  Th2	  cells’	  expression	  of	  Il-­‐13.	  Primers	  of	  the	  promoter	  region	  of	  
Il-­‐5	  should	  be	  designed	  and	  the	  methylation	  should	  be	  analyzed	  to	  look	  at	  any	  correlation	  
between	  its	  methylation	  and	  production	  in	  the	  BAL	  fluid.	  	  
Also,	  as	  GATA-­‐3	  and	  T-­‐bet	  are	  important	  transcription	  factors	  aiding	  in	  T-­‐cell	  
differentiation,	  their	  epigenetic	  alterations	  may	  play	  a	  crucial	  role	  in	  Th2	  polarization	  and	  
the	  production	  of	  pro-­‐allergic	  or	  regulatory	  cytokines.	  It	  is	  not	  known	  to	  what	  extent	  DNA	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methylation	  plays	  in	  their	  expression	  and	  prenatal	  ETS	  exposure	  may	  alter	  their	  
methylation	  patterns	  and	  therefore	  increases	  asthma	  susceptibility.	  	  Studies	  analyzing	  the	  
promoter	  region	  methylation	  of	  GATA-­‐3,	  T-­‐bet	  and	  other	  allergy	  or	  inflammation	  related	  
genes	  would	  allow	  for	  a	  much	  better	  understanding	  of	  how	  epigenetic	  mechanisms	  play	  a	  
role	  in	  allergic	  asthma.	  
	  It	  is	  important	  to	  determine	  the	  mechanism	  by	  which	  allergic	  airway	  inflammation	  
and	  asthma	  develop.	  Epigenetic	  mechanisms	  like	  DNA	  methylation,	  are	  reversible,	  and	  
could	  potentially	  be	  used	  as	  a	  therapeutic	  for	  this	  disease.	  Once	  the	  genes	  and	  CpG	  
locations	  that	  are	  altered	  in	  this	  disease	  are	  identified,	  further	  mechanistic	  studies	  should	  
be	  done	  to	  determine	  what	  machinery	  is	  responsible	  for	  the	  methylation/demethylation,	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